BioCentury
ARTICLE | Company News

Biofield, ValiRx deal

January 5, 2009 8:00 AM UTC

Biofield received an exclusive, worldwide license to distribute a human papillomavirus (HPV) diagnostic test for cervical cancer from ValiRx's ValBio S.A. subsidiary. Biofield purchased a 10% equity s...